文献速递心血管胸部CT

住院COVID-19患者CT心肌细胞外容积评估与肺栓塞的相关性

Myocardial extracellular volume assessment at CT in hospitalized COVID-19 patients with regards to pulmonary embolism.
PubMed 文献 · Eur J Radiol · 2023-04-07

回顾性纳入94例住院COVID-19患者,利用平扫及门静脉期CT计算心肌细胞外容积(ECV),比较有无肺栓塞(PE)患者的ECV差异。PE患者心肌ECV显著高于无PE者(33.5% vs 29.8%,p=0.010),且ECV与年龄、性别、扫描参数及对比剂剂量无相关性。CT-derived ECV可能有助于识别COVID-19患者中与PE相关的心脏功能障碍高风险者。

要点

  • COVID-19合并PE患者心肌ECV较无PE者升高,提示PE可能与心肌间质扩张相关。
  • CT-derived ECV可在常规增强CT门静脉期基础上计算,无需额外扫描。
  • ECV与年龄、性别、扫描电压、辐射剂量、扫描时机及对比剂剂量均无显著相关性。

诊断标准与关键数值

  • 心肌ECV通过感兴趣区置于心肌室间隔及左心室血池计算,采用平扫及门静脉期扫描。
  • PE患者心肌ECV为33.5%(IQR 29.4-37.5%),无PE者为29.8%(IQR 25.1-34.0%),p=0.010。

临床应用与阅片要点

  • 在COVID-19住院患者增强CT门静脉期图像上,可尝试计算心肌ECV以辅助评估心肌间质状态。
  • 对于合并PE的COVID-19患者,应关注心肌ECV升高可能提示心脏功能障碍风险。

局限性

  • 单中心回顾性设计,样本量有限(94例),可能存在选择偏倚。
  • 未报告ECV与临床结局(如心脏功能、预后)的直接关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate myocardial status through the assessment of extracellular volume (ECV) calculated at computed tomography (CT) in patients hospitalized for novel coronavirus disease (COVID-19), with regards to the presence of pulmonary embolism (PE) as a risk factor for cardiac dysfunction.

METHOD: Hospitalized patients with COVID-19 who underwent contrast-enhanced CT at our institution were retrospectively included in this study and grouped with regards to the presence of PE. Unenhanced and portal venous phase scans were used to calculate ECV by placing regions of interest in the myocardial septum and left ventricular blood pool. ECV values were compared between patients with and without PE, and correlations between ECV values and clinical or technical variables were subsequently appraised.

RESULTS: Ninety-four patients were included, 63/94 of whom males (67%), with a median age of 70 (IQR 56-76 years); 28/94 (30%) patients presented with PE. Patients with PE had a higher myocardial ECV than those without (33.5%, IQR 29.4-37.5% versus 29.8%, IQR 25.1-34.0%; p = 0.010). There were no correlations between ECV and patients' age (p = 0.870) or sex (p = 0.122), unenhanced scan voltage (p = 0.822), portal phase scan voltage (p = 0.631), overall radiation dose (p = 0.569), portal phase scan timing (p = 0.460), and contrast agent dose (p = 0.563).

CONCLUSIONS: CT-derived ECV could help identify COVID-19 patients at higher risk of cardiac dysfunction, especially when related to PE, to potentially plan a dedicated, patient-tailored clinical approach.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Monti, Zanardo, Capra, et al. Myocardial extracellular volume assessment at CT in hospitalized COVID-19 patients with regards to pulmonary embolism. Eur J Radiol. 2023. PMID: 37062205. doi:10.1016/j.ejrad.2023.110809

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。